
James Davis/X
Mar 5, 2025, 12:14
James Davis: Dexamethasone for CRS with teclistamab in R/R Multiple Myeloma
James Davis, Assistant professor and malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article he and his colleagues authored on X:
“Hot off the press!
Dexamethasone for CRS with teclistamab. You don’t need toci for grade 1 CRS! great team work.”
Authors: James Davis et al.
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, reshared the post on X, adding:
“Congrats James Davis et al for great Blood Cancer Journal work!
Consider prescribing “pocket dex” for patients following Multiple Myeloma bsAbs. 10mg for Gr1 CRS after ing with team. Easier for pts, easier for centers, works well, and much cheaper than toci!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22